{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:09:59Z","timestamp":1792782599408,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016209","name":"Bilimsel Ara\u015ft\u0131rma Projeleri, Erciyes \u00dcniversitesi","doi-asserted-by":"publisher","award":["TBD-2022-11791"],"award-info":[{"award-number":["TBD-2022-11791"]}],"id":[{"id":"10.13039\/501100016209","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Erciyes University","id":[{"id":"https:\/\/ror.org\/047g8vk19","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Therapeutic management of osteosarcoma and chondrosarcoma is limited by cisplatin (CP)-associated systemic toxicity and acquired chemoresistance. Strategies enabling effective dose reduction while maintaining antitumor activity are urgently required. This study investigated whether melatonin (MEL) and cannabinoids (CBD, THC) enhance CP efficacy through synergistic, multi-target mechanisms in osteosarcoma (MG63, Saos2) and chondrosarcoma (SW1353) cells, with normal fibroblast (FL) and osteoblast (HC) cells as controls. Cytotoxicity and antiproliferative effects were evaluated using MTT and LDH assays. Drug interactions were quantified via combination index (CI) and dose-reduction index (DRI) analyses. Apoptotic mechanisms were assessed by Casp3, Casp8, Casp9, and Bax gene expression, DNA fragmentation, DAPI nuclear staining, and Rhodamine-123-based mitochondrial membrane potential analysis. Anti-migratory and anti-invasive effects were examined using wound-healing and invasion assays. Molecular docking was performed to predict interactions with COX-2, MMPs, ADAMTS-5, and MAPK pathway proteins. Combination regimens, particularly THC\u2009+\u2009CP\u2009+\u2009MEL, and CP\u2009+\u2009MEL, demonstrated strong synergism (CI\u2009&lt;\u20091) in SW1353 and Saos2 cells, enabling up to a 2.77 - 4.38-fold reduction in CP dose. Synergistic treatments significantly upregulated apoptotic markers and induced selective DNA fragmentation, chromatin condensation, and mitochondrial depolarization in cancer cells, while normal cells showed minimal alterations. Cannabinoids markedly suppressed migration and invasion, effects further enhanced in combination treatments. Docking analyses supported high-affinity multi-target interactions consistent with the observed biological responses. Collectively, melatonin enhances cannabinoid-mediated chemosensitization to cisplatin through selective, pro-apoptotic and anti-invasive mechanisms, supporting a low-dose, multi-target combinatorial strategy for bone sarcoma therapy.<\/jats:p>","DOI":"10.1007\/s00210-026-05551-y","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T02:57:54Z","timestamp":1782529074000},"page":"19709-19722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A selective low-dose cisplatin strategy enabled by melatonin and cannabinoids for targeting osteosarcoma and chondrosarcoma"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5011-9286","authenticated-orcid":false,"given":"Davut","family":"Ayd\u0131n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8179-3798","authenticated-orcid":false,"given":"Aylin Korkmaz","family":"P\u0131narba\u015f\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5952-906X","authenticated-orcid":false,"given":"K\u00fcbra","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9550-9111","authenticated-orcid":false,"given":"Ali","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0978-8311","authenticated-orcid":false,"given":"Halit","family":"Canatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"5551_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13404-018-00251-9","volume":"52","author":"A Ayd\u0131n","year":"2019","unstructured":"Ayd\u0131n A, Karada\u011f A, Tekin \u015e, Akba\u015f H (2019) Three new dicyanidoaurate(I)-based complexes exhibiting significant antiproliferative property: synthesis and characterization. Gold Bull 52:35\u201350. https:\/\/doi.org\/10.1007\/s13404-018-00251-9","journal-title":"Gold Bull"},{"issue":"11","key":"5551_CR2","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1089\/jmf.2020.0143","volume":"24","author":"D Ayd\u0131n","year":"2021","unstructured":"Ayd\u0131n D, \u00d6zkan K, Ayd\u0131n A (2021) The combination of amygdalin with some anticancer, antiparasitic, and antigout drugs against MG63, Saos2, SW1353, and FL cells in vitro. J Med Food 24(11):1230\u20131234. https:\/\/doi.org\/10.1089\/jmf.2020.0143","journal-title":"J Med Food"},{"key":"5551_CR3","doi-asserted-by":"publisher","unstructured":"Aydin A, Korkmaz \u015eA. Evaluation of Pharmacological activity of heterobimetallic coordination compounds containing N, N-Bis (2-hydroxyethyl)-ethylenediamine on HT29, hela, C6 and Vero cells. Iran J Pharm Res: IJPR. 2019;18(4):2011. https:\/\/doi.org\/10.22037\/ijpr.2019.1100854","DOI":"10.22037\/ijpr.2019.1100854"},{"key":"5551_CR4","doi-asserted-by":"publisher","unstructured":"Besser E, Gelfand A, Procaccia S, Berman P, Meiri D. Cannabinoid combination targets NOTCH1-mutated T-cell acute lymphoblastic leukemia through the integrated stress response pathway. Elife. 2024 Sep 11;12:RP90854. https:\/\/doi.org\/10.7554\/eLife.90854","DOI":"10.7554\/eLife.90854"},{"key":"5551_CR5","doi-asserted-by":"publisher","unstructured":"Chakravarti B, Ravi J, Ganju RK, 2014. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget 15(15), 5852\u201372. https:\/\/doi.org\/10.18632\/oncotarget.2233","DOI":"10.18632\/oncotarget.2233"},{"issue":"3","key":"5551_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58(3):621\u2013681. https:\/\/doi.org\/10.1124\/pr.58.3.10","journal-title":"Pharmacol Rev"},{"key":"5551_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0165-6147(83)90490-X","volume":"4","author":"TC Chou","year":"1983","unstructured":"Chou TC, Talalay P (1983) Analysis of combined drug effects: a new look at a very old problem. Trends Pharmacol Sci 4:450\u2013454. https:\/\/doi.org\/10.1016\/0165-6147(83)90490-X","journal-title":"Trends Pharmacol Sci"},{"key":"5551_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0022-1759(88)90310-9","volume":"15","author":"T Decker","year":"1988","unstructured":"Decker T, Lohmann-Matthes M-L (1988) A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immun Meth 15:61\u201369. https:\/\/doi.org\/10.1016\/0022-1759(88)90310-9","journal-title":"J Immun Meth"},{"issue":"3","key":"5551_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/0005-2728(86)90112-x","volume":"850","author":"RK Emaus","year":"1986","unstructured":"Emaus RK, Grunwald R, Lemasters JJ (1986) Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties. Biochim Biophys Acta 850(3):436\u2013448. https:\/\/doi.org\/10.1016\/0005-2728(86)90112-x","journal-title":"Biochim Biophys Acta"},{"key":"5551_CR10","first-page":"6933","volume":"48","author":"LJ Erkell","year":"1988","unstructured":"Erkell LJ, Schirrmacher V (1988) Quantitative in vitro assay for tumor cell invasion through extracellular matrix or into protein gels. Cancer Res 48:6933","journal-title":"Cancer Res"},{"key":"5551_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12935-019-1044-2","volume":"19","author":"H Fathizadeh","year":"2019","unstructured":"Fathizadeh H, Mirzaei H, Asemi Z (2019) Melatonin: an anti-tumor agent for osteosarcoma. Cancer Cell Int 19:319. https:\/\/doi.org\/10.1186\/s12935-019-1044-2","journal-title":"Cancer Cell Int"},{"key":"5551_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1006\/abio.1994.1184","volume":"218","author":"J Gong","year":"1994","unstructured":"Gong J, Traganos F, Darzynkiewicz Z (1994) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 218:314\u2013319. https:\/\/doi.org\/10.1006\/abio.1994.1184","journal-title":"Anal Biochem"},{"issue":"12","key":"5551_CR13","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.3390\/cancers13122878","volume":"13","author":"CM Hattinger","year":"2021","unstructured":"Hattinger CM, Patrizio MP, Fantoni L, Casotti C, Riganti C, Serra M (2021) Drug resistance in osteosarcoma: emerging biomarkers, therapeutic targets and treatment strategies. Cancers 13(12):2878. https:\/\/doi.org\/10.3390\/cancers13122878","journal-title":"Cancers"},{"key":"5551_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/BF02497655","volume":"105","author":"S Hirose","year":"1992","unstructured":"Hirose S, Komamine A (1992) Observations of mitochondria and mitochondrial nuclei by double staining with rhodamine-123 and DAPI in synchronous cultures of Catharanthus roseus. Bot Mag Tokyo 105:405\u2013411. https:\/\/doi.org\/10.1007\/BF02497655","journal-title":"Bot Mag Tokyo"},{"key":"5551_CR15","doi-asserted-by":"publisher","unstructured":"\u0130lhan-Ceylan B, Ayd\u0131n A, H\u00fcsamio\u011flu M, Bolukbasi-Yalcinkaya O, K\u00f6se M, K\u00fc\u00e7\u00fckdeniz T Kurt Y, 2025. Dose-dependent multifunctional effects of oxovanadium(IV) thiosemicarbazone complexes: a molecular modeling approach. Inorg Chem Commun 182. https:\/\/doi.org\/10.1016\/j.inoche.2025.115371","DOI":"10.1016\/j.inoche.2025.115371"},{"issue":"1","key":"5551_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s43440-021-00324-1","volume":"74","author":"L Kazantseva","year":"2021","unstructured":"Kazantseva L, Becerra J, Santos-Ruiz L (2021) Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells. Pharmacol Rep 74(1):248. https:\/\/doi.org\/10.1007\/s43440-021-00324-1","journal-title":"Pharmacol Rep"},{"issue":"15","key":"5551_CR17","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.3390\/molecules27155008","volume":"27","author":"L Kazantseva","year":"2022","unstructured":"Kazantseva L, Becerra J, Santos-Ruiz L (2022) Traditional medicinal plants as a source of inspiration for osteosarcoma therapy. Molecules 27(15):5008. https:\/\/doi.org\/10.3390\/molecules27155008","journal-title":"Molecules"},{"key":"5551_CR18","doi-asserted-by":"publisher","unstructured":"Ku\u015f\u00e7u S, Hayran Y, Ayd\u0131n A, 2025. Investigation of the effect of cannabidiol, tetrahydrocannabinol, and vancomycin combination on cariogenic bacterial retention due to microleakage under prosthetic restorations. J Med Palliat Care 6(4), 298\u2013304. https:\/\/doi.org\/10.47582\/jompac.1703800","DOI":"10.47582\/jompac.1703800"},{"key":"5551_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41417-025-00894-9","volume":"32","author":"S Li","year":"2025","unstructured":"Li S, Li Z, Wang J, Han X, Zhang L (2025) Cardamom synergizes with cisplatin against human osteosarcoma cells by mTOR-mediated autophagy. Cancer Gene Ther 32:538\u2013549. https:\/\/doi.org\/10.1038\/s41417-025-00894-9","journal-title":"Cancer Gene Ther"},{"key":"5551_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"CC Liang","year":"2007","unstructured":"Liang CC, Park A, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2:329\u2013333. https:\/\/doi.org\/10.1038\/nprot.2007.30","journal-title":"Nat Protoc"},{"issue":"4","key":"5551_CR21","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/00001622-200007000-00009","volume":"6","author":"WC Mertens","year":"1994","unstructured":"Mertens WC, Bramwell V (1994) Osteosarcoma and other tumors of bone. Curr Opin Oncol 6(4):384\u2013390. https:\/\/doi.org\/10.1097\/00001622-200007000-00009","journal-title":"Curr Opin Oncol"},{"key":"5551_CR22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12935-022-02825-2","volume":"22","author":"A Mihanfar","year":"2022","unstructured":"Mihanfar A, Yousefi B, Azizzadeh B (2022) Interactions of melatonin with various signaling pathways: implications for cancer therapy. Cancer Cell Int 22:420. https:\/\/doi.org\/10.1186\/s12935-022-02825-2","journal-title":"Cancer Cell Int"},{"issue":"7","key":"5551_CR23","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/cncr.24121","volume":"115","author":"L Mirabello","year":"2009","unstructured":"Mirabello L, Troisi RJ, Savage SA (2009) Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 115(7):1531\u20131543. https:\/\/doi.org\/10.1002\/cncr.24121","journal-title":"Cancer"},{"issue":"38","key":"5551_CR24","doi-asserted-by":"publisher","first-page":"e23706","DOI":"10.1002\/jbt.23706","volume":"2024","author":"BA M\u0131s\u0131r","year":"2024","unstructured":"M\u0131s\u0131r BA, Derin Y, \u00d6kten S, Aydin A, Ko\u00e7yi\u011fit \u00dcM, \u015eahin H, Tutar A (2024) Novel diarylated tacrine derivatives: synthesis, characterization, anticancer, antiepileptic, antibacterial, and antifungal activities. J Biochem Mol Toxicol 2024(38):e23706. https:\/\/doi.org\/10.1002\/jbt.23706","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"5551_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1):55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4","journal-title":"J Immunol Methods"},{"issue":"1","key":"5551_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3892\/or.2019.7150","volume":"42","author":"T Nakashima","year":"2019","unstructured":"Nakashima T, Nagano S, Setoguchi T, Sasaki H, Saitoh Y, Maeda S, Komiya S, Taniguchi N (2019) Tranilast enhances the effect of anticancer agents in osteosarcoma. Oncol Rep 42(1):176\u2013188. https:\/\/doi.org\/10.3892\/or.2019.7150","journal-title":"Oncol Rep"},{"issue":"9","key":"5551_CR27","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45. https:\/\/doi.org\/10.1093\/nar\/29.9.e45","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"5551_CR28","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/annonc\/mdp502","volume":"21","author":"P Picci","year":"2010","unstructured":"Picci P, Mercuri M, Ferrari S, Alberghini M, Briccoli A, Ferrari C, Pignotti E, Bacci G (2010) Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Ann Oncol 21(6):1366\u20131373. https:\/\/doi.org\/10.1093\/annonc\/mdp502","journal-title":"Ann Oncol"},{"key":"5551_CR29","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1096\/fj.11-198184","volume":"26","author":"R Ramer","year":"2012","unstructured":"Ramer R, Bublitz K, Freimuth N, Merkord J, Rohde H, Haustein M, Borchert P, Schmuhl E, Linnebacher M, Hinz B (2012) Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J 26:1535\u20131548. https:\/\/doi.org\/10.1096\/fj.11-198184","journal-title":"FASEB J"},{"issue":"11","key":"5551_CR30","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1007\/s11912-024-01589-4","volume":"26","author":"M Sk\u00f3rzewska","year":"2024","unstructured":"Sk\u00f3rzewska M, G\u0119ca K (2024) The role of cannabinoids in advancing cancer treatment: insights from evidence-based medicine. Curr Oncol Rep 26(11):1334. https:\/\/doi.org\/10.1007\/s11912-024-01589-4","journal-title":"Curr Oncol Rep"},{"issue":"9","key":"5551_CR31","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3390\/molecules26092506","volume":"26","author":"WH Talib","year":"2021","unstructured":"Talib WH, Alsayed AR, Abuawad A, Daoud S, Mahmod AI (2021) Melatonin in cancer treatment: current knowledge and future opportunities. Molecules 26(9):2506. https:\/\/doi.org\/10.3390\/molecules26092506","journal-title":"Molecules"},{"key":"5551_CR32","doi-asserted-by":"publisher","unstructured":"Yasukawa M, Liu Y, Hu L, Cogdell D, Gharpure KM, Pradeep S, Nagaraja AS, Sood AK, Zhang W. ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy. Oncotarget. 2016 Aug 8;8(51):88410. https:\/\/doi.org\/10.18632\/oncotarget.11120","DOI":"10.18632\/oncotarget.11120"},{"issue":"4","key":"5551_CR33","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/ph18040520","volume":"18","author":"M Zhra","year":"2025","unstructured":"Zhra M, Akhund SA, Mohammad KS (2025) Advancements in osteosarcoma therapy: overcoming chemotherapy resistance and exploring novel pharmacological strategies. Pharmaceuticals 18(4):520. https:\/\/doi.org\/10.3390\/ph18040520","journal-title":"Pharmaceuticals"},{"issue":"6","key":"5551_CR34","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/medicina61060960","volume":"61","author":"MO Ziyadano\u011fullar\u0131","year":"2025","unstructured":"Ziyadano\u011fullar\u0131 MO, Tuncer MC, \u00d6zdem\u0131r \u0130 (2025) Antitumor effects of hesperidin and cisplatin on human osteosarcoma cells through inhibiting proliferation and inducing mitochondrial-mediated apoptosis. Medicina 61(6):960. https:\/\/doi.org\/10.3390\/medicina61060960","journal-title":"Medicina"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05551-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05551-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05551-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:13:50Z","timestamp":1789978430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05551-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5551"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05551-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}